About 5 results found for searched term "BMS641" (0.057 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M10959 | BMS-641988 | Androgen Receptor |
| BMS-641988 is an androgen receptor (AR) inhibitor that may be used in studies related to prostate cancer. | ||
| M25197 | Ogalvibart | Anti-infection |
| C-135-LS; BMS-986414 | ||
| Ogalvibart (C-135-LS) is a humanized anti-SARS-CoV-2 monoclonal antibody (IgG1 type). Ogalvibart binds to the spike (S) glycoprotein receptor-binding domain (RBD) of SARS-CoV-2. Ogalvibart in combination with C144LS (1:1 ratio) shows good preventive activity and can effectively block the development of COVID19 in a rhesus monkey disease model. | ||
| M30301 | BMS-566419 | Others |
| BMS-566419 is an acridone-based inhibitors of inosine 5'-monophosphate dehydrogenase (IMPDH). Inosine monophosphate dehydrogenase (IMPDH) is a key enzyme in the de novo synthesis of guanosine nucleotides. BMS-566419 has clinical utility for the research of transplant rejection. | ||
| M55691 | BMS641 | RAR/RXR |
| BMS-209641; BMS-641 | ||
| BMS641 (BMS-209641) is a selective RARβ agonist. BMS641 has a higher affinity for RARβ (Kd=2.5 nM) that is 100 times higher than that for RARα (Kd=225 nM) or RARγ (Kd=223 nM). | ||
| M58039 | BMS 326412 | Others |
| BMS 326412 | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
